Rituxan Hycela (rituximab/hyaluronidase human) 1600 mg/13.4 mL Single-Dose Vial **Refrigerated Item** sleeping tablets Injection into a swollen joint

Injection into a swollen joint can rapidly reduce pain and stiffness

reducing the power consumption by an average of 15% or more when compared with other similar units

it is contraindicated in asthma unless the patient is also on an inhaled corticosteroid

reliable absorption for patients with oral intolerance or severe need

This dual action of stimulating stomach and intestinal contractions while reducing nausea makes Metoclopramide Injection an effective treatment for a variety of gastrointestinal disorders

Rituxan Hycela (rituximab/hyaluronidase human) 1600 mg/13.4 mL Single-Dose Vial **Refrigerated Item** sleeping tablets Injection into a swollen jointRituxan Hycela (rituximab hyaluronidase human) 1600 mg is used for the treatment of certain types of cancer and autoimmune diseases. It combines rituximab, an antibody targeting CD20 positive B cells, with hyaluronidase to enhance absorption. This formulation is indicated for Non Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, and certain cases of pemphigus vulgaris. By depleting B cells, it helps reduce disease activity and manage symptoms, offering